Dow Down0.18% Nasdaq Up0.39%

Opexa Therapeutics, Inc. (OPXA)

-NasdaqCM
1.46 Up 0.01(0.69%) 3:59PM EDT
Income StatementGet Income Statement for:
View: Annual Data | Quarterly DataAll numbers in thousands
Period EndingDec 31, 2013Dec 31, 2012Dec 31, 2011
Total Revenue 1,267   -   -  
Cost of Revenue -   -   -  
Gross Profit 1,267   -   -  
Operating Expenses
Research Development9,181  6,318  3,340  
Selling General and Administrative3,671  2,509  2,406  
Non Recurring -   -   -  
Others336  304  210  
Total Operating Expenses -   -   -  
Operating Income or Loss (11,923) (9,134) (5,966)
Income from Continuing Operations
Total Other Income/Expenses Net(2,468)550  (9)
Earnings Before Interest And Taxes(11,872)(8,584)(5,975)
Interest Expense2,267  350  3  
Income Before Tax(14,140)(8,934)(5,978)
Income Tax Expense -   -   -  
Minority Interest -   -   -  
Net Income From Continuing Ops(16,658)(8,934)(5,978)
Non-recurring Events
Discontinued Operations -   -   -  
Extraordinary Items -   -   -  
Effect Of Accounting Changes -   -   -  
Other Items -   -   -  
Net Income (16,656) (8,931) (5,968)
Preferred Stock And Other Adjustments -   -   -  
Net Income Applicable To Common Shares (16,656) (8,931) (5,968)

Sign Up for a Free Trial to EDGAR Online Premium!
Get the critical business and financial information you need for more than 15,000 U.S. public companies.
Sign Up Now - Learn More

Currency in USD.